Jyoti Mishra <br/><br/>
In silico screenng of FDA-approved drugs and natural proteins of omicron and design of new inhibitors for main protease (Mpro) of SARS-CoV-2 

 - 2022 
 - 49 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Physical Science